Given the increase in circulating CD34+ cells in the peripheral blood of MPN patients and the importance of S1P in the egress of HSCs from the bone marrow [11, 36] these observations are of clinical relevance. This evidence concerns the gene CD34 and myeloproliferative neoplasm.